Source: Health Canada shortage reports · Updated Jul 9, 2026
Ropivacaine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A local anesthetic used to numb an area during surgery or to manage pain.
Products affected
0 / 8
Reports on file
68
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
NAROPIN
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02229418 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
NAROPIN
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02229418 · ended Feb 24, 2026 · Disruption of the manufacture of the drug.
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
10MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439409 · ended Dec 8, 2025 · Disruption of the manufacture of the drug.
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
2MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439379 · ended Dec 1, 2025 · Demand increase for the drug.
Resolved
NAROPIN
5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02229415 · ended Feb 11, 2026 · Disruption of the manufacture of the drug.
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
2MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439379 · ended Feb 1, 2026
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
2MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439379 · ended Feb 1, 2026
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
2MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439379 · ended Dec 1, 2025 · Demand increase for the drug.
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
10MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439409 · ended Sep 17, 2025 · Disruption of the manufacture of the drug.
Resolved
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
2MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02439379 · ended Sep 9, 2025 · Due to a delay in the release, we will be encountering a supply interruption on our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 200 mL Bag.
Resolved
NAROPIN
2MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02229411 · ended May 8, 2025 · Disruption of the manufacture of the drug.
Discontinued
NAROPIN
2MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02229411
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Ropivacaine. Health Canada has 68 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Ropivacaine is classified under “ANESTHETICS, LOCAL” (ATC N01BB).
Recent changes
No changes recorded yet.
Common questions
What is Ropivacaine used for?
A local anesthetic used to numb an area during surgery or to manage pain.
When will Ropivacaine be back in stock in Canada?
Ropivacaine has no active shortage; supply is normal per Health Canada reports.
Why is Ropivacaine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.